Sabra Healthcare REIT Q2 2025 presentation: Strategic positioning drives 4% NAFFO growth

Sabra Health Care REIT (SBRA) released an investor presentation following solid Q1 2025 results, with EPS meeting and revenue slightly exceeding expectations, and provided full-year 2025 normalized AFFO per share guidance of $1.49-$1.51, representing 4% year-over-year growth at the midpoint. The company is strategically positioned to benefit from favorable demographic trends in senior care, particularly the growing 80+ population and supply constraints in skilled nursing, maintaining strong occupancy rates and a robust balance sheet with $1.2 billion in liquidity and no material debt until 2028. Despite trading at a 12.0x forward FFO multiple and 6.7% dividend yield (both noted as lower than peer averages), Sabra anticipates continued growth driven by favorable reimbursement trends and a disciplined investment approach.

Analysis

Sabra Health Care REIT (SBRA) presents a compelling investment case grounded in strong secular tailwinds and solid operational execution, as detailed in its recent investor presentation. The company's Q1 2025 performance met EPS expectations at $0.17 and slightly exceeded revenue forecasts at $183.54 million, supporting its full-year 2025 guidance for normalized AFFO per diluted common share of $1.49-$1.51, which implies a 4% year-over-year growth at the midpoint. The core of Sabra's strategy lies in capitalizing on the significant supply-demand imbalance in senior care, where the 80+ population is projected to grow 4% annually while skilled nursing bed supply has contracted by 12% since 2000. This is reflected in strong portfolio occupancy, notably 83% in skilled nursing and 90% in leased senior housing. Financially, SBRA maintains a robust, investment-grade balance sheet with approximately $1.2 billion in liquidity and no material debt maturities until 2028. Valuation appears attractive, with the company trading at a 12.0x forward FFO multiple, which is below its peer group average. While its 51% concentration in skilled nursing and a corresponding EBITDARM coverage of 2.27x lag some peers, this is partially offset by stronger-than-peer coverage in its senior housing segment (1.49x) and positive forward-looking catalysts, including finalized Medicare rate increases of 3.2% and anticipated Medicaid rate growth.

Key Decisions for Investors

• Given the positive full-year guidance, strong demographic tailwinds, and an attractive valuation relative to peers at a 12.0x forward FFO multiple, investors could view SBRA as a compelling long-term holding in the healthcare real estate sector.
• The 6.7% dividend yield appears well-supported by a strong balance sheet with no near-term debt maturities and favorable reimbursement trends, making it a consideration for income-focused portfolios.
• Investors should monitor the company's relatively high concentration in skilled nursing and its EBITDARM coverage ratios in this segment, as these represent key points of differentiation and potential risk compared to more diversified peers.
• Keep a close watch on management's execution of its stated 'robust pipeline of deals' to ensure that future acquisitions are accretive and align with its disciplined capital allocation strategy.